Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...

Amgen Inc. (NASDAQ:AMGN) is one of the stocks on Jim Cramer’s recent game plan. Cramer said that he heard good things about the company during the JPMorgan Healthcare Conference, as he commented: With ...

An updated edition of the December 16, 2025, article. An aging U.S. population is becoming a first-order driver of consumption reallocation. Going by the data from the United States Census Bureau, by ...

Dow Jones biotech giant Amgen, along with fellow biotech stocks Gilead and Vertex, are due to report fourth-quarter earnings ...

Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...

The plant will help make Lilly's experimental drug called retatrutide, which has shown the highest weight loss seen to date in a late-stage trial.

Eli Lilly plans injectable manufacturing site in Pennsylvania, creating 850 jobs and producing next-gen weight-loss medicines by 2031.

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...

Prompt injections have become one of the biggest emerging threats to the modern home as AI adoption grows. It's a new era of malware -- and one that requires new defenses. Tyler Lacoma Editor / Home ...

Gov. Ron DeSantis on Jan. 9 signed a death warrant for Ronald Heath, 64, who would be the first Florida inmate executed in ...